Manatuck Hill Partners’s Immunogen Inc IMGN Stock Holding History

Manatuck Hill Partners’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-50,000	Closed	-$255K	–	114
2019 Q4	$255K	Buy	+50,000	New	+$170K	0.13%	83

Other funds holding IMGN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Manatuck Hill Partners's IMGN Position: Q1 2020 in Review

Manatuck Hill Partners sold out of Immunogen Inc (IMGN) in Q1 2020, closing a stake of 50,000 shares — an estimated $255K sold.

Manatuck Hill Partners first reported a position in IMGN in Q4 2019 and held it in 1 quarter. The position peaked at $255K in Q4 2019. 185 funds tracked by Wall St. Rank hold IMGN as of Q1 2020.

Manatuck Hill Partners reported no remaining Immunogen Inc position as of Q1 2020 after selling out during the quarter.
Manatuck Hill Partners sold 50,000 Immunogen Inc shares in Q1 2020, an estimated $255K.
Manatuck Hill Partners first reported a position in Immunogen Inc in Q4 2019 and held it in 1 quarter.
Manatuck Hill Partners's Immunogen Inc position peaked at $255K in Q4 2019.
185 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2020.

Based on Manatuck Hill Partners's 13F filing for Q1 2020, filed 15 May 2020.